22 May 2013
Keywords: bany, delay, rofecoxib, filing, japan, banyu, pharmaceutical
Article | 03 March 2003
Japan's Banyu Pharmaceutical, which is in the throes of a wrangle overits takeover by majority shareholder Merck & Co (see page 5), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.